This may help explain the failure of previous clinical trials of TLR4 inhibitors and supports the concept of biomarker-guided precision medicine approaches in sepsis.<h4>Trial registration</h4>German Clinical Trials Register (DRKS), DRKS00018871, retrospectively registered on 14 November 2019. The gene discussed is TLR4; the disease is Sepsis.